Lifestance Health Group (LFST)
NASDAQ:LFST
Want to see LFST full AI Analyst Report?
Total Valuation
Lifestance Health Group has a market cap or net worth of $3.08B. The enterprise value is $2.99B.
Market Cap$3.08B
Enterprise Value$2.99B
Share Statistics
Lifestance Health Group has 387,834,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding387,834,440
Owned by Insiders60.16%
Owned by Institutions3.14%
Financial Efficiency
Lifestance Health Group’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 1.01%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.01%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee189.02K
Profits Per Employee1.28K
Employee Count7,535
Asset Turnover0.65
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lifestance Health Group is 43.3. Lifestance Health Group’s PEG ratio is -2.34.
PE Ratio43.3
PS Ratio1.91
PB Ratio1.79
Price to Fair Value1.79
Price to FCF24.70
Price to Operating Cash Flow17.20
PEG Ratio-2.34
Income Statement
In the last 12 months, Lifestance Health Group had revenue of 1.42B and earned 9.66M in profits. Earnings per share was 0.03.
Revenue1.42B
Gross Profit406.35M
Operating Income25.71M
Pretax Income12.36M
Net Income9.66M
EBITDA78.78M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 182.35M and capital expenditures -3.60M, giving a free cash flow of 178.75M billion.
Operating Cash Flow182.35M
Free Cash Flow178.75M
Free Cash Flow per Share0.46
Dividends & Yields
Lifestance Health Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change41.11%
50-Day Moving Average6.73
200-Day Moving Average5.99
Relative Strength Index (RSI)61.38
Average Volume (3m)1.80M
Important Dates
Lifestance Health Group upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Lifestance Health Group as a current ratio of 1.65, with Debt / Equity ratio of 13.28%
Current Ratio1.65
Quick Ratio1.65
Debt to Market Cap0.07
Net Debt to EBITDA-0.69
Interest Coverage Ratio2.20
Taxes
In the past 12 months, Lifestance Health Group has paid 2.70M in taxes.
Income Tax2.70M
Effective Tax Rate0.22
Enterprise Valuation
Lifestance Health Group EV to EBITDA ratio is 33.80, with an EV/FCF ratio of 24.20.
EV to Sales1.87
EV to EBITDA33.80
EV to Free Cash Flow24.20
EV to Operating Cash Flow18.22
Balance Sheet
Lifestance Health Group has $194.80M in cash and marketable securities with $196.19M in debt, giving a net cash position of -$1.39M billion.
Cash & Marketable Securities$194.80M
Total Debt$196.19M
Net Cash-$1.39M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$0.13
Margins
Gross margin is 29.87%, with operating margin of 1.80%, and net profit margin of 0.68%.
Gross Margin29.87%
Operating Margin1.80%
Pretax Margin0.87%
Net Profit Margin0.68%
EBITDA Margin5.53%
EBIT Margin1.69%
Analyst Forecast
The average price target for Lifestance Health Group is $10.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.25
Price Target Upside48.77% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast16.46%
EPS Growth Forecast―